Korean J Anat.  2003 Aug;36(4):257-264.

Quantitative Analysis of Agmatine by HPLC in Ischemic Brain

Affiliations
  • 1Department of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Korea.
  • 2BK21 Project for Medical Sciences, Department of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Korea. jelee@yumc.yonsei.ac.kr

Abstract

Agmatine, a widely distributed molecule in mammalian tissues, shows neuroprotective effects in brain ischemia. We describe the neuroprotective effects of agmatine in the mouse MCAO model and the quantitative change of agmatine in ischemic injury. Brain ischemic injured mice were injected with agmatine (100 mg/kg of mouse, IP). Agmatine significantly reduced the infarct area after MCAO. Despite the similar patterns of agmatine change observed in control or agmatine injected animals, the agmatine levels of the penumbra were significantly higher than those of the striatum and the cerebral cortex during the early period (<1 hour after 2 hours of MCA occlusion). This suggests that the early period, during which agmatine levels increase in the brain, is the crucial period in terms of neuroprotective effect during ischemia.

Keyword

Agmatine; Cerebral ischemia; Reperfusion; Neuroprotective effect; MCAO

MeSH Terms

Agmatine*
Animals
Brain Ischemia
Brain*
Cerebral Cortex
Chromatography, High Pressure Liquid*
Ischemia
Mice
Neuroprotective Agents
Reperfusion
Agmatine
Neuroprotective Agents
Full Text Links
  • KJA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr